Skip to content

Search

The ARC Centre of Excellence for Children and Families over the Life Course (Life Course Centre or LCC)

The Life Course Centre is a national centre funded by the Australian Research Council Centre of Excellence Scheme and hosted through the University o…

Gifted pump proves a life changer for family

Oliver Bowman is too young to understand the enormity of having type 1 diabetes but his young parents Brooke and Aidan know all too well the reality…

Language in Little Ones (LiLO)

The Language in Little Ones (LiLO) study is a five-year longitudinal study (2017-2021), funded through the National Health and Medical Research Counc…

Young people in detention facing significant communication barriers

A study revealing significant levels of language difficulty among detainees at the Banksia Hill Detention Centre underscores the need for more suppor…

The Kids study hopes to help kids with neuromuscular disorders sleep more easily

Mackenzie was 10 months old when her parents, Jodie and Scott, were given the life-changing news that their daughter would never walk.

A CHAF1B-Dependent Molecular Switch in Hematopoiesis and Leukemia Pathogenesis

Here we report that CHAF1B is required for normal hematopoiesis while its overexpression promotes leukemia

An economic case for a vaccine to prevent group A streptococcus skin infections

A vaccine that prevents GAS cellulitis and other skin infections, in addition to throat infections, would maximise its value and commercial viability

Impact of biobanks on research outcomes in rare diseases: a systematic review

This review made the important observation that registries with biobanks had the function of both stand-alone registries and stand-alone rare disease…

BHP funds help researchers reach for the sky

Two The Kids researchers will launch innovative new scientific projects thanks to funding from BHP.

Sarcoma Translational Research

We aim to discover and develop safer and more effective treatments by doing inventive and rigorous research to improve outcomes for kids with cancer.